Sessions
Exploring the latest biomaterial scaffolds, hydrogels, and delivery matrices to enhance cell survival and functional integration. Focus on optimizing microenvironments to support advanced therapeutic outcomes.
Session on novel viral and non-viral vector innovations built for higher efficiency, targeted delivery, and improved patient safety. Includes breakthroughs in AAV, lentiviral, and synthetic vector designs.
Covers evolution in CAR-T cell engineering, including armored CARs, universal allogeneic CARs, and improvements for solid tumors. Emphasis on durability, persistence, and reduced toxicity.
Latest translational advancements using embryonic, adult, and induced pluripotent stem cells for tissue and organ repair. Real clinical case progress and scalability challenges highlighted.
Deep dive into CRISPR-Cas systems and next-gen tools like base and prime editing for safer, more accurate genomic correction. Addresses regulatory concerns and real-world applications.
Focus on overcoming solid tumor barriers with enhanced infiltration, tumor microenvironment modulation, and combination therapeutic strategies. Highlights clinical progress in multiple cancer types.
Showcases automation, robotics, and digital control for reproducible, scalable, and lower-cost therapy production. Includes success stories transitioning from lab to GMP facilities.
Discusses milestones and challenges in advancing gene therapies through trial pipelines toward real-world implementation. Patient response variability and trial design strategies included.
Covers long-term monitoring, immunogenicity reduction, off-target analysis, and tumorigenicity prevention in advanced therapies. Regulatory frameworks for patient safety emphasized.
Examines the promise of exosomes as natural delivery systems for genetic cargo and regenerative signals. Includes manufacturing hurdles and evolving clinical evidence.
Covers universal donor cell lines enabling off-the-shelf treatment models. Examines immunologic compatibility and scalable production approaches.
Focuses on nanoparticle, lipid, and polymer-based gene transfer technologies. Discusses efficiency, biodistribution, and safety advantages.
Explores engineered tissues and bio-printed constructs for functional repair. Showcases translational examples in skin, bone, and cartilage regeneration.
Discusses cell reprogramming, gene circuits, and logic-based therapeutic designs. Highlights programmable immune and stem cell systems.
Demonstrates AI-driven modeling for productivity, potency, and process prediction. Focuses on digital twins and smart manufacturing.
Examines advanced analytical assays for potency, purity, and stability. Includes process validation and regulatory expectations.
Reviews compliance standards, facility design, and validation protocols under GMP. Focuses on consistency and safety in therapeutic manufacturing.
Covers CGT approaches for Parkinson’s, ALS, and Alzheimer’s. Includes neuro-repair, vector targeting, and delivery innovations.
Addresses unique ethical and physiological challenges in pediatric populations. Discusses clinical data, dosing, and parental consent frameworks.
Explores CGT approaches to reset immune balance in autoimmune diseases. Focuses on T-cell reprogramming and antigen-specific tolerance
Covers breakthroughs in single-gene disorder therapies and orphan indications. Highlights success stories and funding pathways.
Explores RNA-based therapeutics for transient, controllable gene correction. Discusses mRNA, siRNA, and antisense oligonucleotide advances.
Focuses on cell freezing, thawing, and long-term storage innovations. Addresses maintaining viability and potency post-storage.
Discusses molecular and cellular biomarkers for therapy tracking. Highlights predictive tools for patient response.